A pilot study investigating the influence of glucagon-like peptide-1 receptor single nucleotide polymorphisms on gastric emptying rate in Caucasian Men by Yau, Adora M. W. et al.
fphys-09-01331 September 21, 2018 Time: 14:45 # 1
ORIGINAL RESEARCH
published: 25 September 2018
doi: 10.3389/fphys.2018.01331
Edited by:
Ravinder Abrol,
California State University, Northridge,
United States
Reviewed by:
Manlio Vinciguerra,
International Clinical Research Center
(FNUSA-ICRC), Czechia
Matthias J. Bahr,
Sana Kliniken Lübeck, Germany
*Correspondence:
Gethin H. Evans
gethin.evans@mmu.ac.uk
Specialty section:
This article was submitted to
Gastrointestinal Sciences,
a section of the journal
Frontiers in Physiology
Received: 13 March 2018
Accepted: 04 September 2018
Published: 25 September 2018
Citation:
Yau AMW, McLaughlin J,
Maughan RJ, Gilmore W, Ashworth JJ
and Evans GH (2018) A Pilot Study
Investigating the Influence
of Glucagon-Like Peptide-1 Receptor
Single Nucleotide Polymorphisms on
Gastric Emptying Rate in Caucasian
Men. Front. Physiol. 9:1331.
doi: 10.3389/fphys.2018.01331
A Pilot Study Investigating the
Influence of Glucagon-Like Peptide-1
Receptor Single Nucleotide
Polymorphisms on Gastric Emptying
Rate in Caucasian Men
Adora M. W. Yau1, John McLaughlin2,3, Ronald J. Maughan4, William Gilmore1,5,
Jason J. Ashworth1 and Gethin H. Evans1*
1 School of Healthcare Science, Manchester Metropolitan University, Manchester, United Kingdom, 2 Division of Diabetes,
Endocrinology and Gastroenterology, School of Medical Sciences, The University of Manchester, Manchester,
United Kingdom, 3 Salford Royal Hospitals, Salford, United Kingdom, 4 School of Medicine, University of St Andrews,
St Andrews, United Kingdom, 5 School of Biomedical Sciences, Ulster University, Coleraine, United Kingdom
Gastric emptying rate in humans is subject to large individual variability, but previous
research on the influence of genetics is scarce. Variation in the glucagon-like peptide-1
receptor (GLP1R) gene is a plausible candidate gene to partially explain the high
variance. This study aimed to investigate the influence of genetic variation in the GLP1R
gene on gastric emptying rate of a glucose solution in humans. Forty eight healthy
Caucasian males took part in this investigation. Gastric emptying rate of a 6% glucose
solution was assessed using the 13C breath test method and a venous blood sample
was obtained from each participant. Participants were genotyped for 27 Tag single
nucleotide polymorphisms (SNPs) in the GLP1R locus using Sequenom MassARRAY
iPLEX GOLD analysis and MALDI-TOF mass spectrometry. The time at which maximal
emptying rate occurred (Tlag) was faster in participants with the CC genotype than in TT
and TC genotypes for SNP rs742764: [median (quartiles) CC, 35 (30–36) min vs. TT, 43
(39–46) min, and TC, 41 (39–45) min; P < 0.01]. Tlag was also slower in participants
with the AA genotype compared to the TT and TA genotypes for SNP rs2254336:
[AA, 43 (39–49) min vs. TT, 36 (34–41) min, and TA, 39 (35–42) min; P < 0.05].
Analysis by phenotype also showed differences in half-emptying time (T1/2) and Tlag for
SNPs rs9283907, rs2268657, and rs2254336. Several neighboring Tag SNPs within
the GLP1R gene were found to be associated with gastric emptying rate, and should
be further investigated.
Keywords: GLP-1 receptor, single nucleotide polymorphisms, gastric emptying rate, GLP-1, gastrointestinal
motility
INTRODUCTION
An increasing number of genetic variants within the genes coding for gastrointestinal hormones
and their receptors are being found to be associated with obesity phenotypes, appetite, and food
regulation. As many of the gastrointestinal hormones involved in appetite regulation also play a
role in the regulation of gastric emptying, it is possible that genetic variations in gastrointestinal
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hormones associated with obesity may affect gastric emptying
rate. However, research on the potential influence of genetics
on gastric emptying rate is scarce. Acosta et al. (2014) reported
a common genetic variant rs17782313 in the Melanocortin 4
receptor (MC4R) gene, which has previously been found to be
strongly associated with common obesity (Loos et al., 2008; Vogel
et al., 2011), to be associated with reduced gastric emptying
rate and satiation. In addition, Cremonini et al. (2005) found
an association between the 779T > C polymorphism in the
cholecystokinin (CCK) gene and slower gastric emptying rate. On
the other hand, Jones et al. (2010) found no effect of common
genetic polymorphisms of the CCK or CCK-1 receptor genes on
gastric emptying rate.
Genetic variation within a gene related to the action of
the gastrointestinal hormone glucagon-like peptide-1 (GLP-1)
presents a plausible area of investigation, as GLP-1 has been
shown to influence gastric emptying rate (Wettergren et al.,
1993; Wishart et al., 1998). Furthermore, large inter-individual
variations in gastric emptying rate of a glucose solution as
well as the large differences in GLP-1 hormone responses to
carbohydrate ingestion have been observed (Yau et al., 2014,
2017). GLP-1 exerts its effects via a G-protein coupled receptor
called the GLP-1 receptor (GLP1R). Stimulation of this receptor
by GLP-1 triggers cAMP production as the primary signal
transduction pathway (Mayo et al., 2003). The GLP1R recognizes
GLP-1 specifically despite the hormone having strong sequence
homology to other hormones within the glucagon-related family
of peptides, and furthermore, does not bind to a number of other
related peptides, including secretin (Fehmann et al., 1994).
Genetic polymorphisms of the GLP1R gene have previously
been investigated in relation to insulin secretion (Sathananthan
et al., 2010) and the pathogenesis of diabetes (Tanizawa et al.,
1994; Tokuyama et al., 2004; Beinborn et al., 2005). Only
one study has previously investigated the influence of GLP1R
genetic variation on gastric emptying rate, but in mice (Kumar
et al., 2008). The presence of a non-synonymous cysteine to
tyrosine substitution at amino acid 416 of the GLP1R gene
found in CAST strain mice was associated with reduced GLP1R
expression and significantly faster (by 20%) gastric emptying rate
compared to B6 strain mice. This was also seen for the congenic
strains where gastric emptying rate was significantly higher
in B6.CAST-17 congenic mice compared to homozygous B6
controls. Furthermore, administration of the GLP1R antagonist
extendin-(9-36) resulted in no increase in gastric emptying rate
compared to a 10% increase in the homozygous B6 control mice.
The GLP1R gene is therefore a plausible candidate gene for a
genetic association study on gastric emptying rate in humans.
The human GLP1R gene consists of 13 exons interrupted by 12
introns (Wilmen et al., 1998) and is situated on chromosome
6, band p21.1 (Stoffel et al., 1993). A major transcription start
point and a minor transcription start point 42 base pairs (bp) and
360 bp upstream of the translation initiation site, respectively,
have been reported (Lankat-Buttgereit and Goke, 1997). Three
putative Sp1 binding sites have also been located in the proximal
5′ flanking sequence at −108, −173, and −389 bp from the
translation initiation codon (Lankat-Buttgereit and Goke, 1997).
The receptor is 463 amino acids in length and is highly conserved
between species with 90% being identical to rat GLP1R (Dillon
et al., 1993) and approximately 95% homology with mice GLP1R.
The primary aim of this study was to investigate the influence of
genetic variation in the GLP1R gene on gastric emptying rate of a
glucose solution in humans.
MATERIALS AND METHODS
Ethical Approval
Forty eight British and South-Western European Caucasian
males aged 18–35 years (mean ± SD, age 23 ± 5 years,
height 178 ± 7 cm, body mass 75.8 ± 11.2 kg, body mass
index 23.9 ± 3.3 kg.m−2, and estimated body fat percentage
19 ± 6%) volunteered for this study. All participants were
non-smokers, were not taking medication with any known effect
on gastrointestinal function, and had no known history of
chronic gastrointestinal disease or other medical conditions as
assessed by a medical screening questionnaire. All participants
provided written informed consent prior to participation. The
study was granted prior ethical approval from the Manchester
Metropolitan University Ethical Advisory committee and was
performed in accordance with the Declaration of Helsinki (2008).
Experimental Trial
All participants attended the laboratory for one experimental
trial. In the 24 h preceding the trial, participants were requested
to refrain from alcohol and caffeine consumption, and the
performance of strenuous physical activity. Participants arrived
at the laboratory in the morning following an overnight fast
from 2100 h, with the exception of drinking 500 mL of water
90 min prior to arrival at the laboratory, in an attempt to ensure
a consistent and adequate hydration status.
Upon arrival at the laboratory, participants were asked
to completely empty their bladder. Body mass was then
recorded. Following this, a whole blood sample was obtained
by venipuncture of an antecubital vein. Once this procedure
was completed, participants ingested 595 mL of a 6% glucose
solution as quickly as they were comfortably able over a
maximum period of 2 min. Test solutions were prepared
fresh on the morning of the trial containing 39.6 g glucose
monohydrate1 dissolved in water and made up to a volume
of 600 mL. In addition, solutions contained 100 mg of 13C
sodium acetate (Cambridge Isotopes Laboratories, Inc., Andover,
MA, United States) for the assessment of gastric emptying rate.
The drink was served at ambient temperature and a 5 mL
sample retained for later analysis of osmolality. Participants
remained seated throughout a 60 min post-ingestion sampling
period where end expiratory breath samples were collected
at baseline then every 10 min after ingestion into foil bags
(Wagner Analyzen-Technik, Breman, Germany) by exhalation
through a mouthpiece. Bags were then sealed with a plastic
stopper and stored for later analysis. Breath samples were
analyzed for the ratio of 13CO2 to 12CO2 by non-dispersive
infrared spectroscopy, with the difference in the ratio from
1MyProtein.com
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TABLE 2 | SNP genotype frequencies.
Genotype
SNP ID Homozygous minor allele Heterozygous Homozygous major allele
Genotype n Genotype n Genotype n Total
1 rs7738586 AA 0 CA 10 CC 38 48
2 rs9380825 AA 5 AG 28 GG 15 48
4 rs926674 TT 3 TC 6 CC 39 48
5 rs2268657 GG 9 AG 27 AA 11 47
6 rs13202369 GG 2 AG 21 AA 25 48
7 rs3799707 TT 3 GT 19 GG 26 48
8 rs10305432 CC 3 CT 19 TT 26 48
9 rs9283907 AA 1 AG 9 GG 38 48
10 rs742764 CC 8 TC 25 TT 14 47
11 rs2254336 TT 9 TA 23 AA 16 48
12 rs910163 CC 3 TC 18 TT 27 48
14 rs6923761 AA 7 GA 28 GG 13 48
15 rs7766663 GG 10 GT 23 TT 15 48
16 rs932443 GG 5 AG 21 AA 22 48
17 rs2268646 AA 0 AG 10 GG 38 48
18 rs2300614 TT 5 CT 21 CC 22 48
19 rs2268641 AA 4 AG 21 GG 22 47
20 rs2268640 CC 3 TC 18 TT 27 48
21 rs2268639 TT 3 TA 22 AA 22 48
22 rs2206942 AA 6 AG 24 GG 18 48
23 rs2894420 AA 9 AG 27 GG 11 47
26 rs4714211 GG 7 AG 27 AA 13 47
27 rs10305525 AA 0 CA 9 CC 39 48
28 rs9296291 CC 3 TC 17 TT 28 48
29 rs9968886 AA 0 GA 12 GG 36 48
30 rs2143733 GG 7 GT 27 TT 14 48
31 rs9296292 CC 4 CT 20 TT 24 48
baseline to post-breath samples expressed as delta over baseline
(DOB). Half emptying time (T1/2) and the time at which
maximal emptying rate occurred (Tlag) were calculated using
the manufacturer’s integrated software evaluation embedded
with equations previously described (Ghoos et al., 1993). Each
participant’s own physiological CO2 production assumed as
300 mmol CO2 per m2 body surface per hour was set as default
and body surface area was calculated by the integrated software
according to a previously described formula (Haycock et al.,
1978). Following all sample collections at 60 min, participants
were free to leave the laboratory.
Genotyping
Genomic DNA was extracted from 3 mL of whole blood using
Flexigene DNA Kit (Qiagen, West Sussex, United Kingdom),
according to the manufacturer’s instructions, except for the final
step of resuspension in 300 µL of nuclease-free ultrapure water.
Extracted DNA was subsequently quantified using a NanoDrop
2000 (Thermo Scientific, 116 Loughborough, United Kingdom)
and normalized to a concentration of 40 ng/µL then stored at
−20◦C before working concentrations of 20 ng/µL were prepared
in 96-well plate format prior to use.
Twenty-eight tag single nucleotide polymorphisms (SNPs)
in the GLP1R locus incorporating 10,000 bp upstream and
downstream of the major transcription initiation site and the
last exon, respectively (Chr6: 39114595....39173498) were selected
from HapMap2 (HapMap Data release 27/phase II + III, Feb09,
on NCBI B36 assembly, dbSNP b126). The Tagger algorithm for
multi-marker tagging with r2 > 0.8 and minor allele frequency
(MAF) > 0.1 was used (de Bakker et al., 2005). Furthermore,
three additional non-synonymous SNPs were selected based on
previous literature. One of two SNPs found to be associated with
insulin secretion in response to exogenous infusion of GLP-1
by Sathananthan et al. (2010), which was not already in the
generated list of 28 tag SNPs was genotyped. The other two
additional SNPs genotyped were two in very close proximity (two
amino acids upstream and three amino acids downstream) to
the equivalent locus of the SNP found in mice to be associated
with gastric emptying rate (Kumar et al., 2008). All 31 SNPs
were genotyped using Sequenom MassARRAY iPLEX GOLD
analysis. Forward and reverse primers as well as extension probes
were designed using Sequenom Assay Design Suite (v1.0) which
2www.hapmap.org
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TABLE 3 | Gastric emptying Tlag results according to genotype.
SNP ID Homozygous minor allele Heterozygous Homozygous major allele P-value
Genotype Median Quartiles Genotype Median Quartiles Genotype Median Quartiles
1 rs7738586 – – – CA 37 34–41 CC 40 37–45 0.274
2 rs9380825 AA 42 61–80 AG 41 37–45 GG 37 36–40 0.349
4 rs926674 TT 37 37–41 TC 38 36–40 CC 41 36–46 0.448
5 rs2268657 GG 42 37–44 AG 38 37–46 AA 37 34–39 0.087
6 rs13202369 GG 34 31–36 AG 41 37–49 AA 39 36–42 0.295
7 rs3799707 TT 42 36–43 GT 40 35–43 GG 40 37–45 0.696
8 rs10305432 CC 36 35–37 CT 41 39–43 TT 40 35–46 0.267
9 rs9283907 AA 29 29–29 AG 37 35–41 GG 41 37–44 0.158
10 rs742764 CC 35∗ 30–36 TC 41 39–45 TT 41 37–46 0.008
11 rs2254336 TT 36 34–41 TA 39 35–42 AA 43† 39–49 0.031
12 rs910163 CC 37 37–39 TC 40 36–45 TT 41 36–44 0.788
14 rs6923761 AA 43 41–48 GA 40 37–43 GG 37 34–41 0.222
15 rs7766663 GG 36 31–40 GT 40 38–44 TT 42 37–48 0.076
16 rs932443 GG 37 36–41 AG 40 38–45 AA 41 35–44 0.634
17 rs2268646 – – – AG 40 37–48 GG 40 35–43 0.493
18 rs2300614 TT 36 35–37 CT 40 37–44 CC 42 36–46 0.210
19 rs2268641 AA 37 37–38 AG 40 35–44 GG 41 35–44 0.724
20 rs2268640 CC 37 37–39 TC 40 34–45 TT 41 37–44 0.741
21 rs2268639 TT 37 37–39 TA 40 35–44 AA 41 36–44 0.816
22 rs2206942 AA 39 37–51 AG 40 36–43 GG 41 32–46 0.878
23 rs2894420 AA 43 39–49 AG 39 36–42 GG 37 36–48 0.470
26 rs4714211 GG 36 33–39 AG 40 37–45 AA 41 37–44 0.244
27 rs10305525 – – – CA 37 36–41 CC 40 36–45 0.369
28 rs9296291 CC 37 37–39 TC 40 35–45 TT 41 37–43 0.812
29 rs9968886 – – – GA 37 36–45 GG 41 36–43 0.543
30 rs2143733 GG 37 37–48 GT 39 35–43 TT 42 39–48 0.549
31 rs9296292 CC 37 34–38 CT 39 34–44 TT 41 38–45 0.166
Values are minutes. ∗Significantly faster than other two genotypes (P < 0.01). †Significantly slower than other two genotypes (P < 0.05). Bold values indicate significant
difference.
produced two appropriate assay plexes; plex 1 containing 24
SNPs and plex 2 containing seven SNPs (Table 1). Primers
were purchased from Metabion International AG (Martinsreid,
Germany).
Briefly, an initial locus-specific amplification was performed
using polymerase chain reaction (PCR; GeneAmp PCR System
9700, Applied Biosystems) carried out in a total volume of 5 µL
containing 40 ng of DNA and final concentrations of 1.25x buffer,
1.0 mM MgCl2, 500 µM dNTP mix, 100 nM of each forward
and reverse primers, and 0.1 U/µL Hotstart Taq. PCR conditions
consisted of an initial denaturing step at 94◦C for 5 min, followed
by 40 cycles of denaturing at 94◦C for 20 s, annealing at 56◦C for
30 s and extension at 72◦C for 1 min, and then a final extension
step at 72◦C for 3 min. Unincorporated dNTPs within the PCR
products were dephosphorylated by incubation for 40 min at
37◦C followed by 5 min at 85◦C with 2 µL Shrimp Alkaline
Phosphatase (SAP) mixture composed of 1.7 µL 1x hME buffer
and 0.3 µL SAP 1.7 U/µL. A single base extension step was then
performed with the addition of 2 µL reaction mix containing
50µM of each ddNTP, 3.3:6.6µM extension probe from low:high
mass (2.8:5.6 µM for plex 2), 1.0x buffer, and 1.25 U Thermo
Sequenase. Probe extension conditions consisted of a two-step
200 short cycle program involving initial denaturing at 94◦C for
30 s, 40 cycles of denaturing at 94◦C for 5 s, annealing at 52◦C
for 5 s, and extension at 80◦C for 5 s where the annealing and
extension steps also cycled five times, before a final extension
at 72◦C for 3 min. Resulting products were diluted with 20 µL
nuclease-free ultrapure water and desalted with 6 mg resin by
gentle inversion for 10 min before centrifugation at 4000 rpm
for 5 min. Products were subsequently nano-dispensed (Samsung
Sequenom MassARRAY Nanodispenser) onto a 384-element
SpectroCHIP II bioarray and analyzed by MALDI-TOF mass
spectrometry.
Data and Statistical Analysis
Genotype results were visually checked and appropriate manual
genotype assignment was made upon spectrum inspection where
no automated genotype calling had successfully taken place.
Differences in gastric emptying T1/2 and Tlag were examined
between genotype and phenotype groups. For each SNP analyzed,
it was hypothesized that there was a significant difference in
gastric emptying rate between genotype groups or phenotype
groups. Normality tests indicated that the majority of data
were not normally distributed. Furthermore, as group sizes
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TABLE 4 | Gastric emptying T1/2 results according to genotype.
SNP ID Homozygous minor allele Heterozygous Homozygous major allele P-value
Genotype Median Quartiles Genotype Median Quartiles Genotype Median Quartiles
1 rs7738586 – – – CA 62 56–72 CC 64 55–79 0.919
2 rs9380825 AA 71 61–80 AG 64 56–80 GG 60 55–70 0.650
4 rs926674 TT 59 56–62 TC 60 55–71 CC 64 56–82 0.569
5 rs2268657 GG 72 59–83 AG 61 56–73 AA 59 53-67 0.203
6 rs13202369 GG 70 58–81 AG 62 54–77 AA 64 56–73 0.935
7 rs3799707 TT 61 57–66 GT 59 54–83 GG 66 59–78 0.452
8 rs10305432 CC 59 56–71 CT 65 57–75 TT 62 55–80 0.852
9 rs9283907 AA 41 41–41 AG 56 54–62 GG 67 59–82 0.054
10 rs742764 CC 54 53–59 TC 66 56–80 TT 66 59–81 0.061
11 rs2254336 TT 59 53–68 TA 62 54–75 AA 71 62–85 0.138
12 rs910163 CC 59 56–60 TC 66 54–82 TT 62 57–73 0.431
14 rs6923761 AA 72 66–81 GA 62 56–74 GG 59 54–83 0.297
15 rs7766663 GG 57 53–66 GT 62 54–79 TT 71 61–81 0.168
16 rs932443 GG 60 59–68 AG 65 54–83 AA 62 57–72 0.820
17 rs2268646 – – – AG 67 57–87 GG 63 54–76 0.485
18 rs2300614 TT 54 53–59 CT 65 54–83 CC 66 58–73 0.120
19 rs2268641 AA 57 54–59 AG 65 54–80 GG 63 58–73 0.283
20 rs2268640 CC 59 56–60 TC 66 54–82 TT 62 57–73 0.453
21 rs2268639 TT 59 56–60 TA 65 55–79 AA 63 56–73 0.475
22 rs2206942 AA 60 57–86 AG 65 55–78 GG 63 55–73 0.959
23 rs2894420 AA 72 64–92 AG 62 55–72 GG 59 54–81 0.187
26 rs4714211 GG 54 54–60 AG 64 56–75 AA 68 59–89 0.233
27 rs10305525 – – – CA 59 55–68 CC 64 55–79 0.412
28 rs9296291 CC 59 56–60 TC 66 54–83 TT 62 56–72 0.386
29 rs9968886 – – – GA 61 56–92 GG 65 54–74 0.934
30 rs2143733 GG 59 55–77 GT 64 55–79 TT 65 59–73 0.791
31 rs9296292 CC 56 52–59 CT 65 54–81 TT 66 60–77 0.125
Values are minutes.
were unequal, non-parametric statistical analysis comprising
Kruskal–Wallace and Mann–Whitney U-tests were utilized
accordingly. Where appropriate, post hoc tests of Mann–Whitney
U with Bonferroni correction were applied. All data were
analyzed using SPSS Statistics for Windows (IBM, New York,
NY, United States). Statistical significance was accepted at the 5%
level and results presented as median and quartiles unless stated
otherwise.
RESULTS
SNP Genotyping
Twenty-seven of the 31 SNPs were successfully analyzed for
variants. No variants occurred among the participants for three
SNPs, Tag SNP 3 within the promoter region (rs9296274) and
two of the three selected missense polymorphism, SNPs 24
(rs199796313) and 25 (rs200691429). Genotyping failed in all
participants for SNP 13 (rs3765467), one of the three additional
missense SNPs. The occasional failure to successfully genotype
one participant occurred in five SNPs, reducing the total
participant number (n) to 47 instead of 48. Frequencies of each
genotype are shown in Table 2.
Gastric Emptying Rate
Mean± SD gastric emptying rate for all participants was 68± 16
and 41 ± 8 min for T1/2 and Tlag, respectively. Median (quartiles)
gastric emptying rate for all participants was 63 (55–78) and 40
(36–44) min for T1/2 and Tlag, respectively.
By Genotype
Results for Tlag and T1/2 according to genotype are shown in
Tables 3, 4, respectively. Differences in median gastric emptying
Tlag were seen for SNP 10 rs742764 and SNP 11 rs2254336. For
SNP 10 rs742764, gastric emptying Tlag was faster in genotype
CC compared to genotype TT (P = 0.006) and TC (P = 0.006)
by 15%. T1/2 was also tending to significance with differences
of 18% (P = 0.061). For SNP 11 rs2254336, gastric emptying
Tlag was slower in genotype AA compared to genotype TT
(P = 0.04) and TA (P = 0.036) by 19 and 10%, respectively.
T1/2 showed a slight trend to be slower than both other groups
by 20 and 15% but this did not reach statistical significance
(P = 0.138). No significant differences in gastric emptying rate
were seen between genotypes for all other SNPs, although T1/2
tended toward significance for SNP 9 rs9283907 (P = 0.054) and
Tlag tended to significance for SNP 5 rs2268657 (P = 0.087) and
SNP 15 rs7766663 (P = 0.076).
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By Phenotype
Results for Tlag and T1/2 according to phenotype are shown
in Tables 5, 6, respectively. A significant effect of the minor
allele on median gastric emptying T1/2 was seen for SNP 9
rs9283907. Participants with one or two A alleles had faster
T1/2 than participants homozygous for the allele G by 18%
(P = 0.033). A significant effect of the minor allele on median
gastric emptying Tlag was also seen for SNP 5 rs2268657 and
SNP 11 rs2254336. Participants with one or two G alleles
had slower Tlag than participants homozygous for the allele
A by 11% (P = 0.028), and participants with one or two
T alleles had faster Tlag than participants homozygous for
the allele A by 13% (P = 0.012), respectively. No differences
in gastric emptying rate were seen between phenotypes for
all other SNPs, though T1/2 tended toward significance for
SNP 11 rs2254336 (P = 0.055) and SNP 15 rs7766663
(P = 0.097).
Body Mass Index and Body Fat
Percentage
Median (quartiles) BMI for all participants was 23.1 (21.6–25.3)
kg.m−2. No effect of genotype on BMI was found for all
SNPs although SNP 15 rs7766663 tended to significance [GG,
24.5 (21.6–26.2) kg.m−2 vs. GT, 24.0 (22.2–26.0) kg.m−2
vs. TT, 22.1 (21.1–23.3) kg.m−2; P = 0.091]. Analysis by
phenotype, however, revealed median BMI was significantly
higher in participants with one or two minor alleles compared
to homozygotes of the major allele for SNP 12 rs910163
[TT, 22.2 (21.3–24.2) kg.m−2 vs. CC/CT, 24.6 (22.6–26.7)
kg.m−2; P = 0.039] and SNP 15 rs7766663 [TT, 22.1
(21.1–23.3) kg.m−2 vs. GG/GT, 24.0 (22.1–26.3) kg.m−2;
P = 0.028].
Median (quartiles) body fat for all participants was 18.3
(14.1–22.2)%. No effect of genotype nor phenotype was seen for
any SNPs, although SNP 28 rs9296291 tended to significance for
phenotype [TT, 17.2 (13.5–19.7)% vs. CC/CT, 20.8 (15.5–24.9)%;
P = 0.061].
DISCUSSION
The results of this study showed several Tag SNPs of the
GLP1R gene are significantly associated with the gastric
emptying rate of a glucose solution in healthy young Caucasian
men. Two neighboring polymorphisms, SNPs 10 rs742764
TABLE 5 | Gastric emptying Tlag results according to phenotype.
SNP ID Homozygous major allele Heterozygous/homozygous minor allele P-value
Phenotype n Median Quartiles Phenotype n Median Quartiles
1 rs7738586 CC 38 40 37–45 A 10 37 34–41 0.274
2 rs9380825 GG 15 37 36–40 A 33 41 37–44 0.157
4 rs926674 CC 39 41 36–46 T 9 37 36–40 0.239
5 rs2268657 AA 11 37∗ 34–39 G 36 41 37–45 0.028
6 rs13202369 AA 25 39 36–42 G 23 41 36–48 0.627
7 rs3799707 GG 26 40 37–45 T 22 40 34–43 0.396
8 rs10305432 TT 26 40 35–46 C 22 41 37–42 0.844
9 rs9283907 GG 38 41 37–44 A 10 36 33–41 0.137
10 rs742764 TT 14 41 37–46 C 33 40 35–43 0.492
11 rs2254336 AA 16 43 39–49 T 32 39∗ 34–41 0.012
12 rs910163 TT 27 41 36–44 C 21 39 36–44 0.950
14 rs6923761 GG 13 37 34–41 A 35 40 37–44 0.197
15 rs7766663 TT 15 42 37–48 G 33 39 35–42 0.136
16 rs932443 AA 22 41 35–44 G 26 40 36–44 0.983
17 rs2268646 GG 38 40 35–43 A 10 40 37–48 0.493
18 rs2300614 CC 22 42 36–46 T 26 39 35–42 0.330
19 rs2268641 GG 22 41 35–44 A 25 39 36–42 0.856
20 rs2268640 TT 27 41 37–44 C 21 39 35–44 0.546
21 rs2268639 AA 22 41 36–44 T 25 39 35–42 0.701
22 rs2206942 GG 18 41 32–46 A 30 40 36–44 0.806
23 rs2894420 GG 11 37 36–48 A 36 40 36–43 0.930
26 rs4714211 AA 13 41 37–44 G 34 40 35–44 0.497
27 rs10305525 CC 39 40 36–45 A 9 37 36–41 0.369
28 rs9296291 TT 28 41 37–43 C 20 40 35–44 0.908
29 rs9968886 GG 36 41 36–43 A 12 37 36–45 0.543
30 rs2143733 TT 14 42 39–48 G 34 39 35–44 0.276
31 rs9296292 TT 24 41 38–45 C 24 38 34–43 0.107
Values are minutes. ∗Significantly faster emptying rate compared to other phenotype (P < 0.05). Bold values indicate significant difference.
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TABLE 6 | Gastric emptying T1/2 results according to phenotype.
SNP ID Phenotype n Median Quartiles Phenotype n Median Quartiles P-value
1 rs7738586 CC 38 64 55–79 A 10 62 56–72 0.919
2 rs9380825 GG 15 60 55–70 A 33 64 56–80 0.367
4 rs926674 CC 39 64 56–82 T 9 59 54–65 0.355
5 rs2268657 AA 11 59 53–67 G 36 64 56–78 0.119
6 rs13202369 AA 25 64 56–73 G 23 62 54–80 0.757
7 rs3799707 GG 26 66 59–78 T 22 60 54–76 0.218
8 rs10305432 TT 26 62 55–80 C 22 65 55–76 0.836
9 rs9283907 GG 38 67 59–82 A 10 55∗ 53–61 0.033
10 rs742764 TT 14 66 59–81 C 33 62 54–77 0.478
11 rs2254336 AA 16 71 62–85 T 32 60 54–74 0.055
12 rs910163 TT 27 62 57–73 C 21 64 54–80 0.950
14 rs6923761 GG 13 59 54–83 A 35 64 57–75 0.516
15 rs7766663 TT 15 71 61–81 G 33 61 54–77 0.097
16 rs932443 AA 22 62 57–72 G 26 65 54–82 0.702
17 rs2268646 GG 38 63 54–76 A 10 67 57–87 0.485
18 rs2300614 CC 22 66 58–73 T 26 62 54–79 0.521
19 rs2268641 GG 22 63 58–73 A 25 62 54–77 0.733
20 rs2268640 TT 27 62 57–73 C 21 64 54–80 0.755
21 rs2268639 AA 22 65 55–79 T 25 62 54–77 0.806
22 rs2206942 GG 18 63 55–73 A 30 63 55–79 0.774
23 rs2894420 GG 11 59 54–81 A 36 64 56–74 0.715
26 rs4714211 AA 13 68 59–89 G 34 62 54–73 0.385
27 rs10305525 CC 39 64 55–79 A 9 59 55–68 0.412
28 rs9296291 TT 28 62 56–72 C 20 65 54–81 0.875
29 rs9968886 GG 36 65 54–74 A 12 61 56–92 0.934
30 rs2143733 TT 14 65 59–73 G 34 63 54–79 0.691
31 rs9296292 TT 24 66 60–77 C 24 60 54–78 0.239
Values are minutes. ∗Significantly faster emptying rate compared to other phenotype (P < 0.05). Bold values indicate significant difference.
and 11 rs2254336, were found to be significantly associated
with gastric emptying rate by genotype. In addition, SNPs
5 rs2268657, 9 rs9283907, and 15 rs7766663 tended to
significance. Furthermore, three SNPs, 5 rs2268657, 9 rs9283907,
and 11 rs2254336, were found to be significantly associated
with gastric emptying rate by phenotype. SNP 15 rs7766663
also tended to significance. Thus, significant associations
between genetic variation and gastric emptying rate were
found for four Tag SNPs by one or more measures of
genetic association. Tag SNP 5 rs2268657 is situated in
intron one and the other three 9, 10, 11 are situated in
intron 3.
The aforementioned Tag SNPs identified to be associated
with gastric emptying rate signify a region where a causative
variant is most likely to reside (Xia and Grant, 2013). As
three of the associated SNPs are neighboring Tag SNPs, this
presents a genomic region that warrants further investigation
with particularly high interest. Approximately 3000 bp exist
between the locations of SNP 9 rs9283907 and 10 rs742764
and similarly between SNP 10 rs742764 and 11 rs2254336.
Spanning this whole 6132 bp “hot spot” region, a total of
129 SNPs have been sequenced to date. No known functional
SNPs within the GLP1R gene have currently been identified
within this particular region or within introns 1, 3, or 5.
However, it is widely known that SNPs in regulatory elements
residing within intronic regions can alter silencing, enhancer,
or splicing events (Chorev and Carmel, 2012; Lee et al.,
2012). Further work by in silico analysis or multi-array analysis
of all 129 known SNPs within this region to narrow down
on the precise SNP or SNPs responsible for the observed
differences in gastric emptying rate should therefore be
conducted. The genetic variants surrounding SNP 5 rs2268657
in intron one should also be further investigated as SNPs within
intron one of several genes have been shown to influence
gene transcription events (Murani et al., 2009; Berulava and
Horsthemke, 2010).
Variants in the proximity of SNP 15 rs7766663 also provide a
directive area of further research in gastric emptying regulation as
it tended toward significance but was also significantly associated
with BMI by phenotype. This association may signal a link
between gastric emptying rate and BMI but further participants
are required to confirm these concurrent associations. Indeed,
further potential “links” or associations may also be identified
with a much larger sample size which will increase the power of
future studies.
The two additional missense SNPs in close proximity to the
locus of the variant seen in the mice model by Kumar et al.
(2008) did not show any variants in the sample population
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of this present study. It may be that the variant is rare
or non-existent in the Caucasian population. The MAFs for
these two missense SNPs are unknown. The other additional
missense SNP selected for its previous association with insulin
secretion (Sathananthan et al., 2010) also showed no variants
in this participant group. This was mostly likely due to its
small MAF of 0.0646 indicating the SNP is somewhat rare.
Tag SNPs 6 rs13202369 and 14 rs6923761, located in intron
1 and exon 5, respectively, have previously been reported to
alter insulin secretion responses to intravenous GLP-1 (Vella
et al., 2009; Sathananthan et al., 2010). These were not found
to be associated with gastric emptying rate in this study,
however.
CONCLUSION
The results of this targeted gene study to investigate the
potential influence of GLP1R genetic variation on gastric
emptying rate in humans revealed several Tag SNPs to be
associated with gastric emptying rate of a glucose solution in
healthy Caucasian men. This suggests that genetic variation
within the GLP1R gene may influence gastric emptying rate
in humans. Further work should be undertaken to identify
the precise SNP or SNPs responsible and functional analysis
conducted. In addition, this experiment should be replicated
with the use of foods more representative of a typical meal.
Furthermore, this association study should be repeated with a
larger population sample to independently confirm the detected
associations between GLP1R genetic variation and gastric
emptying rate.
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